Published in J Urban Health on November 01, 2006
Disclosure of genital human papillomavirus infection to female sex partners by young men. Sex Transm Dis (2012) 0.81
The Fifth Edition of the Addiction Severity Index. J Subst Abuse Treat (1992) 29.45
Models for longitudinal data: a generalized estimating equation approach. Biometrics (1988) 27.90
From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect (1999) 17.95
Sexually transmitted diseases treatment guidelines 2002. Centers for Disease Control and Prevention. MMWR Recomm Rep (2002) 5.75
Effect of expedited treatment of sex partners on recurrent or persistent gonorrhea or chlamydial infection. N Engl J Med (2005) 3.96
Depressive symptoms and AIDS-related mortality among a multisite cohort of HIV-positive women. Am J Public Health (2004) 2.66
Partner notification for sexually transmitted diseases: an overview of the evidence. Can J Public Health (1995) 1.80
Partner notification in the United States: an evidence-based review. Am J Prev Med (1999) 1.73
A systematic review of strategies for partner notification for sexually transmitted diseases, including HIV/AIDS. Int J STD AIDS (2002) 1.72
Depression and HIV risk behaviors among patients in a sexually transmitted disease clinic. Am J Psychiatry (2004) 1.67
Partner notification for HIV and STD in the United States: low coverage for gonorrhea, chlamydial infection, and HIV. Sex Transm Dis (2003) 1.38
Usefulness of partner notification for syphilis control. Sex Transm Dis (1999) 1.35
Frequency of alcohol use and its association with STD/HIV-related risk practices, attitudes and knowledge among an African-American community-recruited sample. Int J STD AIDS (1998) 1.27
The role of self-efficacy and relationship quality in partner notification by adolescents with sexually transmitted infections. Arch Pediatr Adolesc Med (2002) 1.18
Screening for potentially transmitting sexual risk behaviors, urethral sexually transmitted infection, and sildenafil use among males entering care for HIV infection. AIDS Patient Care STDS (2004) 1.09
Effectiveness of patient delivered partner medication for preventing recurrent Chlamydia trachomatis. Sex Transm Infect (1998) 0.94
Concurrent sexually transmitted infections (STIs) in sex partners of patients with selected STIs: implications for patient-delivered partner therapy. Clin Infect Dis (2005) 0.89
Expedited partner therapy for sexually transmitted diseases. Clin Infect Dis (2005) 0.88
Biologically confirmed sexually transmitted infection and depressive symptomatology among African-American female adolescents. Sex Transm Infect (2006) 0.84
Mental health disorders and sexually transmitted diseases in a privately insured population. Am J Manag Care (2004) 0.81
Effect of expedited treatment of sex partners on recurrent or persistent gonorrhea or chlamydial infection. N Engl J Med (2005) 3.96
Longitudinal predictors of human papillomavirus vaccine initiation among adolescent girls in a high-risk geographic area. Sex Transm Dis (2011) 3.39
Disparities in how parents are learning about the human papillomavirus vaccine. Cancer Epidemiol Biomarkers Prev (2009) 3.07
Sexual and reproductive health of persons aged 10-24 years - United States, 2002-2007. MMWR Surveill Summ (2009) 2.89
Patterns and predictors of changes in adherence to highly active antiretroviral therapy: longitudinal study of men and women. Clin Infect Dis (2007) 2.67
Depressive symptoms and AIDS-related mortality among a multisite cohort of HIV-positive women. Am J Public Health (2004) 2.66
Cerebrospinal fluid abnormalities in patients with syphilis: association with clinical and laboratory features. J Infect Dis (2004) 2.59
Mumps. Lancet (2008) 2.59
Human papillomavirus vaccination practices: a survey of US physicians 18 months after licensure. Pediatrics (2010) 2.48
Measuring retention in HIV care: the elusive gold standard. J Acquir Immune Defic Syndr (2012) 2.47
Chapter 24: Psychosocial aspects of vaccine acceptability. Vaccine (2006) 2.32
Crack cocaine, disease progression, and mortality in a multicenter cohort of HIV-1 positive women. AIDS (2008) 2.28
Vaginal swabs are appropriate specimens for diagnosis of genital tract infection with Chlamydia trachomatis. J Clin Microbiol (2003) 2.24
Normalization of cerebrospinal fluid abnormalities after neurosyphilis therapy: does HIV status matter? Clin Infect Dis (2004) 2.23
Medically eligible women who do not use HAART: the importance of abuse, drug use, and race. Am J Public Health (2004) 2.18
Long-term complications of congenital esophageal atresia and/or tracheoesophageal fistula. Chest (2004) 2.17
Use of highly active antiretroviral therapy in a cohort of HIV-seropositive women. Am J Public Health (2002) 2.15
Incidence of lipoatrophy and lipohypertrophy in the women's interagency HIV study. J Acquir Immune Defic Syndr (2003) 1.95
Prevalence of clinical symptoms associated with highly active antiretroviral therapy in the Women's Interagency HIV Study. Clin Infect Dis (2004) 1.94
The HPV vaccine: a content analysis of online news stories. J Womens Health (Larchmt) (2009) 1.87
Human papillomavirus vaccine initiation in an area with elevated rates of cervical cancer. J Adolesc Health (2009) 1.86
Prevalence and correlates of heterosexual anal and oral sex in adolescents and adults in the United States. J Infect Dis (2007) 1.78
Human papillomavirus vaccine initiation among adolescent girls in high-risk communities. Vaccine (2011) 1.76
Potential barriers to HPV vaccine provision among medical practices in an area with high rates of cervical cancer. J Adolesc Health (2008) 1.76
Risk of progression to AIDS and death in women infected with HIV-1 initiating highly active antiretroviral treatment at different stages of disease. Arch Intern Med (2002) 1.75
Trends in mortality and causes of death among women with HIV in the United States: a 10-year study. J Acquir Immune Defic Syndr (2009) 1.73
An assessment of the GYT: Get Yourself Tested campaign: an integrated approach to sexually transmitted disease prevention communication. Sex Transm Dis (2014) 1.71
A national survey of pediatrician knowledge and attitudes regarding human papillomavirus vaccination. Pediatrics (2006) 1.66
Impact of highly active antiretroviral therapy on anemia and relationship between anemia and survival in a large cohort of HIV-infected women: Women's Interagency HIV Study. J Acquir Immune Defic Syndr (2004) 1.58
An evaluation of the reliability of HIV partner notification disposition coding by disease intervention specialists in the United States. Sex Transm Dis (2009) 1.57
Spatial bridges for the importation of gonorrhea and chlamydial infection. Sex Transm Dis (2003) 1.54
Physicians' STD diagnosis and screening practices in the South. South Med J (2004) 1.51
HIV partner notification in the United States: a national survey of program coverage and outcomes. Sex Transm Dis (2004) 1.49
Self-administered vaginal swabs are a feasible alternative to physician-assisted cervical swabs for sexually transmitted infection screening in the emergency department. Acad Emerg Med (2009) 1.48
Success of an infection control program to reduce the spread of carbapenem-resistant Klebsiella pneumoniae. Infect Control Hosp Epidemiol (2009) 1.43
Association of race, substance abuse, and health insurance coverage with use of highly active antiretroviral therapy among HIV-infected women, 2005. Am J Public Health (2009) 1.43
Activation of CD8 T cells predicts progression of HIV infection in women coinfected with hepatitis C virus. J Infect Dis (2010) 1.42
A low-effort, clinic-wide intervention improves attendance for HIV primary care. Clin Infect Dis (2012) 1.42
Mumps outbreaks in vaccinated populations: are available mumps vaccines effective enough to prevent outbreaks? Clin Infect Dis (2008) 1.42
Disinhibition and risk compensation: scope, definitions, and perspective. Sex Transm Dis (2008) 1.41
Sexual history-taking among primary care physicians. J Natl Med Assoc (2006) 1.39
Partner notification for gonorrhea-time for new ideas. Sex Transm Dis (2007) 1.38
Partner notification for HIV and STD in the United States: low coverage for gonorrhea, chlamydial infection, and HIV. Sex Transm Dis (2003) 1.38
Outbreak of Mycobacterium abscessus wound infections among "lipotourists" from the United States who underwent abdominoplasty in the Dominican Republic. Clin Infect Dis (2008) 1.35
Illicit drug use, depression and their association with highly active antiretroviral therapy in HIV-positive women. Drug Alcohol Depend (2007) 1.28
Peer referral for HIV case-finding among men who have sex with men. AIDS (2006) 1.25
Factors associated with prevalent hepatitis C infection among HIV-infected women with no reported history of injection drug use: the Women's Interagency HIV Study (WIHS). AIDS Patient Care STDS (2009) 1.25
Healthcare use by varied highly active antiretroviral therapy (HAART) strata: HAART use, discontinuation, and naivety. AIDS (2004) 1.22
Assessing mortality in women with hepatitis C virus and HIV using indirect markers of fibrosis. AIDS (2012) 1.21
Contraceptive use among U.S. women with HIV. J Womens Health (Larchmt) (2007) 1.20
Prenatal and postpartum zidovudine adherence among pregnant women with HIV: results of a MEMS substudy from the Perinatal Guidelines Evaluation Project. J Acquir Immune Defic Syndr (2002) 1.19
Depressive symptoms in the immediate postpartum period among Hispanic women in three U.S. cities. J Immigr Health (2004) 1.19
Implementation and evaluation of a clinic-based behavioral intervention: positive steps for patients with HIV. AIDS Patient Care STDS (2008) 1.18
Mumps antibody levels among students before a mumps outbreak: in search of a correlate of immunity. J Infect Dis (2011) 1.17
Longitudinal trends in hazardous alcohol consumption among women with human immunodeficiency virus infection, 1995-2006. Am J Epidemiol (2009) 1.16
Factors associated with hepatitis C viremia in a large cohort of HIV-infected and -uninfected women. J Clin Virol (2008) 1.15
Impact of drug abuse treatment modalities on adherence to ART/HAART among a cohort of HIV seropositive women. Am J Drug Alcohol Abuse (2008) 1.14
Disclosure of complementary and alternative medicine use to health care providers among HIV-infected women. AIDS Patient Care STDS (2009) 1.14
Adult identity mentoring: reducing sexual risk for African-American seventh grade students. J Adolesc Health (2005) 1.14
Neutropenia in human immunodeficiency virus infection: data from the women's interagency HIV study. Arch Intern Med (2006) 1.13
HIV/STI Risk behaviors among Latino migrant workers in New Orleans post-Hurricane Katrina disaster. Sex Transm Dis (2008) 1.12
Psychosocial characteristics and sexual behaviors of people in care for HIV infection: an examination of men who have sex with men, heterosexual men and women. AIDS Behav (2009) 1.12
Human papillomavirus and cervical cancer behavioral surveillance in the US. Cancer (2008) 1.11
Psychosocial and behavioral correlates of depression among HIV-infected pregnant women. AIDS Patient Care STDS (2004) 1.11
The spectrum of engagement in HIV care: do more than 19% of HIV-infected persons in the US have undetectable viral load? Clin Infect Dis (2011) 1.10
A randomized controlled trial for reducing risks for sexually transmitted infections through enhanced patient-based partner notification. Am J Public Health (2008) 1.09
Knowledge of cervical cancer prevention and human papillomavirus among women with HIV. Gynecol Oncol (2010) 1.07
Patterns and predictors of HIV/STI risk among Latino migrant men in a new receiving community. AIDS Behav (2012) 1.07
Syphilis and HIV: a dangerous duo. Expert Rev Anti Infect Ther (2005) 1.07
Alcohol consumption trajectory patterns in adult women with HIV infection. AIDS Behav (2013) 1.03
The association of clinical follow-up intervals in HIV-infected persons with viral suppression on subsequent viral suppression. AIDS Patient Care STDS (2013) 1.02
Prevalence and long-term effects of occult hepatitis B virus infection in HIV-infected women. Clin Infect Dis (2007) 1.01
Longitudinal relationships between use of highly active antiretroviral therapy and satisfaction with care among women living with HIV/AIDS. Am J Public Health (2006) 1.01
Increasing public health partner services for human immunodeficiency virus: results of a second national survey. Sex Transm Dis (2010) 1.00
The cost and cost-effectiveness of expedited partner therapy compared with standard partner referral for the treatment of chlamydia or gonorrhea. Sex Transm Dis (2011) 1.00
Increase in single-tablet regimen use and associated improvements in adherence-related outcomes in HIV-infected women. J Acquir Immune Defic Syndr (2014) 1.00
HIV and sexually transmitted infection risk behaviors and beliefs among Black West Indian immigrants and US-born Blacks. Am J Public Health (2008) 1.00
HIV screening among U.S. physicians, 1999-2000. AIDS Patient Care STDS (2008) 1.00
Medicinal and recreational marijuana use among HIV-infected women in the Women's Interagency HIV Study (WIHS) cohort, 1994-2010. J Acquir Immune Defic Syndr (2012) 0.98
Awareness of hepatitis C infection among women with and at risk for HIV. J Gen Intern Med (2007) 0.98
Comparison of methods to increase repeat testing in persons treated for gonorrhea and/or chlamydia at public sexually transmitted disease clinics. Sex Transm Dis (2004) 0.97
Expedited partner therapy for sexually transmitted diseases: assessing the legal environment. Am J Public Health (2008) 0.97
The V protein of mumps virus plays a critical role in pathogenesis. J Virol (2011) 0.97
Understanding the disparity: predictors of virologic failure in women using highly active antiretroviral therapy vary by race and/or ethnicity. J Acquir Immune Defic Syndr (2013) 0.96
Sequence diversity of Jeryl Lynn strain of mumps virus: quantitative mutant analysis for vaccine quality control. Virology (2002) 0.96
Racial residential segregation and rates of gonorrhea in the United States, 2003-2007. Am J Public Health (2012) 0.96
Sexual serosorting among women with or at risk of HIV infection. AIDS Behav (2011) 0.95
Improved prevention counseling by HIV care providers in a multisite, clinic-based intervention: Positive STEPs. AIDS Educ Prev (2009) 0.95
Hepatitis C seropositivity and kidney function decline among women with HIV: data from the Women's Interagency HIV Study. Am J Kidney Dis (2009) 0.95
Predictors of H1N1 vaccination in pregnancy. Am J Obstet Gynecol (2011) 0.94
A randomized, double-blind study comparing single-dose rifalazil with single-dose azithromycin for the empirical treatment of nongonococcal urethritis in men. Sex Transm Dis (2007) 0.94
Violence during pregnancy among women with or at risk for HIV infection. Am J Public Health (2002) 0.94